Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04198012 · ClinicalTrials.gov registry record · NA
An Open Label Study to Allow Patients Continuous Use of the HemoCare™ Hemodialysis System
A NA study, sponsored by Deka Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04198012: Completed NA study, sponsored by Deka Research and Development.
NCT04198012 is a NA study that has completed, run by Deka Research and Development. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04198012, a NA study, has completed, sponsored by Deka Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study is designed to monitor and assess the safety of continued access to the HemoCare™ Hemodialysis System used during the review of the pre-market notifications for the devices in the HemoCare™ Hemodialysis System.
Primary Outcome
The Total Number of subjects having at least one Anticipated AE, Unanticipated AE, Device Related AE, Anticipated SAE, Unanticipated SAE and Device Related SAEs.
Interventions
- DEVICE HemoCare™ Hemodialysis System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-12-16 |
| Est. Completion | 2024-04-05 |
| Phase | NA |
What the finished NCT04198012 record still lists
NCT04198012 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which HemoCare™ Hemodialysis System is the first listed.
NCT04198012 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04198012 about?
NCT04198012 is a clinical study titled "An Open Label Study to Allow Patients Continuous Use of the HemoCare™ Hemodialysis System". This study is designed to monitor and assess the safety of continued access to the HemoCare™ Hemodialysis System used during the review of the pre-market notifications for the devices in the HemoCare™ Hemodialysis System.
What is the current status of trial NCT04198012?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-12-16. Estimated completion is 2024-04-05.
What interventions are being tested in trial NCT04198012?
The interventions under investigation include: HemoCare™ Hemodialysis System (DEVICE).
Who is sponsoring clinical trial NCT04198012?
This trial is sponsored by Deka Research and Development, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04198012's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI